首页
期刊导航
期刊检索
论文检索
新闻中心
期刊
期刊
论文
首页
>
《中华医学杂志(英文版)》
>
2021年18期
>
Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
(整期优先)网络出版时间:2021-10-10
作者:
Hu Jing-Yi
Zou Hai-Lan
Li Yan-Hua
Nie Dong-Ying
Chao Chen
Liu Jin-Han
Ding Jin
Zhou Zhi-Guang
Xiao Yang
医药卫生
>
分享
打印
同系列资源
资料简介
无
/
1
无
同系列内容
《中华医学杂志(英文版)》2021年18期 - Thyroid cartilage elevation maneuver: a novel and easy-to-perform method to insert a supraglottic airway device
2021-10-10
0
《中华医学杂志(英文版)》2021年18期 - Optic nerve sheath diameter measured using magnetic resonance imaging and factors that influence results in healthy Chinese adults: a cross-sectional study
2021-10-10
0
《中华医学杂志(英文版)》2021年18期 - Rehabilitation and returning to activity after prolonged moderate traumatic brain injury
2021-10-10
0
《中华医学杂志(英文版)》2021年18期 - Adsorptive hemofiltration for sepsis management: expert recommendations based on the Asia Pacific experience
2021-10-10
0
《中华医学杂志(英文版)》2021年18期 - Utility of convolutional neural network-based algorithm in medical images for liver fibrosis assessment
2021-10-10
0
查看全部
来源期刊
中华医学杂志(英文版)
2021年18期
相关推荐
Relationship of serum vitamin D levels with diabetic microvascular complications in patients with type 2 diabetes mellitus
Role of fibroblast growth factor 23 in patients with chronic kidney disease
Hemoglobin structure at higher levels of hemoglobin A1C in type 2 diabetes and associated complications
Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients
Serum microtubule-associated protein light chain 3 type II levels correlate with aggravation and multi-organ dysfunction in septic patients
同分类资源
更多
[医药卫生]
氢吗啡酮和吗啡皮下注射镇痛用于癌性爆发痛的临床效果比较
[医药卫生]
口咽癌放疗中颈部Ⅱ区和口腔靶区优化对涎腺功能及口腔黏膜反应的影响
[医药卫生]
达拉菲尼治疗皮肤黑色素瘤的效果及其对垂体同源框1蛋白表达的影响
[医药卫生]
急性髓系白血病中高剂量阿糖胞苷巩固治疗后医院感染发生情况分析
[医药卫生]
血栓标志物对恶性肿瘤患者术后发生静脉血栓栓塞症的预测价值
相关关键词
Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
/
1
重新阅读
+在线打印
返回顶部